Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset

被引:13
作者
Dotta, F
Falorni, A
Tiberti, C
Dionisi, S
Anastasi, E
Torresi, P
Lernmark, A
Di Mario, U
机构
[1] Univ La Sapienza, Dept Endocrinol, Rome, Italy
[2] Univ RC, Dept Clin & Expt Med, Catanzaro, Italy
[3] Karolinska Inst, Stockholm, Sweden
[4] Univ Washington, Dept Med, Seattle, WA USA
关键词
islet autoimmunity; type; 1; diabetes; glutamic acid decarboxylase (GAD); gangliosides;
D O I
10.1006/jaut.1997.0166
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The GM2-1 islet ganglioside has been sequenced, found to be a novel ganglioside structure with a sialic acid moiety in the terminal position and two residues of non-acetylated galactosamine and also shown to be a target of autoantibodies in a subset of ICA(+) relatives of type 1 diabetic patients who subsequently progressed to the overt disease. In the present study we determined whether antibodies to GM2-1 or to other pancreatic gangliosides (a) are also expressed at disease onset and (b) are correlated with other diabetes-associated autoantibodies. Pancreatic gangliosides were extracted from human pancreas and purified by thin layer chromatography (TLC). Anti-ganglioside autoantibodies were determined using an indirect immunoperoxidase technique performed directly on TLC plates in the following groups of patients: (a) newly diagnosed type 1 diabetic subjects before insulin therapy (n=45); all were tested for GAD65 autoantibodies in a fluid-phase RIA using S-35-methionine-labelled recombinant human GAD65. Of these patients, 24 were also tested for insulin autoantibodies (IAA) by a competitive fluid phase radioimmunoassay and 21 were tested for GAD67 reactivity. (b) Forty-two age-and sex-matched normal control subjects. Autoantibodies to GM2-1, but not to other pancreatic gangliosides (GM3, GD3, GD1a), were expressed in 31 of 45 new-onset type 1 diabetic subjects and in one of 42 normal controls (P<0.01), while anti-GAD65, IAA and anti-GAD67 were found in 31 of 45, 12 of 24 and three of 21 patients respectively, but not in the control group of subjects. Interestingly, occurrence of GM2-1 autoantibodies was significantly correlated (P<0.005) with positivity for GAD65 autoantibodies, but not for IAA or GAD67 autoantibodies. It is of note that both GAD and gangliosides are mainly expressed in islets and in neuronal tissues and, therefore, type 1 diabetes may be regarded as a neuroendocrine autoimmune disease. (C) 1997 Academic Press Limited.
引用
收藏
页码:585 / 588
页数:4
相关论文
共 23 条
  • [1] ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428
  • [2] ISLET-CELL AUTOANTIGENS IN INSULIN-DEPENDENT DIABETES
    ATKINSON, MA
    MACLAREN, NK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1608 - 1616
  • [3] ISLET CELL CYTOPLASMIC AUTOANTIBODY REACTIVITY TO GLUTAMATE-DECARBOXYLASE IN INSULIN-DEPENDENT DIABETES
    ATKINSON, MA
    KAUFMAN, DL
    NEWMAN, D
    TOBIN, AJ
    MACLAREN, NK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) : 350 - 356
  • [4] IDENTIFICATION OF THE 64K AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES AS THE GABA-SYNTHESIZING ENZYME GLUTAMIC-ACID DECARBOXYLASE
    BAEKKESKOV, S
    AANSTOOT, HJ
    CHRISTGAU, S
    REETZ, A
    SOLIMENA, M
    CASCALHO, M
    FOLLI, F
    RICHTEROLESEN, H
    CAMILLI, PD
    [J]. NATURE, 1990, 347 (6289) : 151 - 156
  • [5] ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS WITH AUTOIMMUNE POLY-ENDOCRINE DEFICIENCIES
    BOTTAZZO, GF
    FLORINCH.A
    DONIACH, D
    [J]. LANCET, 1974, 2 (7892) : 1279 - 1283
  • [6] BINDING OF CYTOPLASMIC ISLET CELL ANTIBODIES IS BLOCKED BY HUMAN PANCREATIC GLYCOLIPID EXTRACTS
    COLMAN, PG
    NAYAK, RC
    CAMPBELL, IL
    EISENBARTH, GS
    [J]. DIABETES, 1988, 37 (05) : 645 - 652
  • [7] PANCREATIC-ISLET GANGLIOSIDE EXPRESSION IN NONOBESE DIABETIC MICE - COMPARISON WITH C57BL/10 MICE AND CHANGES AFTER AUTOIMMUNE BETA-CELL DESTRUCTION
    DOTTA, F
    PETERSON, LB
    PREVITI, M
    METZGER, J
    TIBERTI, C
    ANASTASI, E
    ZOPPITELLI, P
    WICKER, LS
    DIMARIO, U
    [J]. ENDOCRINOLOGY, 1992, 130 (01) : 37 - 42
  • [8] GANGLIOSIDE EXPRESSION IN HUMAN PANCREATIC-ISLETS
    DOTTA, F
    COLMAN, PG
    LOMBARDI, D
    SCHARP, DW
    ANDREANI, D
    PONTIERI, GM
    DIMARIO, U
    LENTI, L
    EISENBARTH, GS
    NAYAK, RC
    [J]. DIABETES, 1989, 38 (11) : 1478 - 1483
  • [9] RAT PANCREATIC GANGLIOSIDE EXPRESSION - DIFFERENCES BETWEEN A MODEL OF AUTOIMMUNE ISLET B-CELL DESTRUCTION AND A NORMAL STRAIN
    DOTTA, F
    TIBERTI, C
    PREVITI, M
    ANASTASI, E
    ANDREANI, D
    LENTI, L
    PONTIERI, GM
    GIANANI, R
    APPEL, MC
    EISENBARTH, GS
    DIMARIO, U
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 66 (02): : 143 - 149
  • [10] DOTTA F, 1995, DIABETOLOGIA, V38, P1117, DOI 10.1007/s001250050400